Search
for
Sort by
Research 30 of 273
- Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities
- Kinetic topographical heterogeneity in follicular thyroid neoplasms and growth patterns
- Telitacicept for systemic lupus erythematosus with post‑surgical papillary thyroid carcinoma: A case report
- Antitumor Activities of the Typhonium flagelliforme Extract Combined with Natural Interferons of Canine and Feline in Mice with DMBA Induced Skin Tumors
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Women with alopecia exhibit a higher risk for thyroid cancer: A nationwide cohort study
- Skin diseases in consequence of endocrine alterations
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Dermatologic manifestations of thyroid disease: a literature review
- Potential Consequences of the Use of Adipose-Derived Stem Cells in the Treatment of Hepatocellular Carcinoma
- Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer
- Toward a Unifying Hypothesis for Redesigned Lipid Catabolism as a Clinical Target in Advanced, Treatment-Resistant Carcinomas
- Acquired hypertrichosis lanuginosa: Case report and review of the literature
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Atlas of Geriatric Dermatology
- Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells
- Management of Toxicities of Targeted Therapies
- Hair loss in children.
- Molecular pathology of skin adnexal tumours
- British Society for Dermatopathology
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Ovarian Hilus Cell Hyperplasia and Sertoli-Leydig Cell Tumor in a Patient with Postmenopausal Virilization: a Rare Case Report
- Subject Index
- Extracellular vesicles derived from MSCs activates dermal papilla cell in vitro and promotes hair follicle conversion from telogen to anagen in mice
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Stem Cells Therapies in Basic Science and Translational Medicine: Current Status and Treatment Monitoring Strategies
- Cutaneous reactions to recombinant cytokine therapy
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies